A citation-based method for searching scientific literature

Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A Kushner, Pablo Lapuerta, Darren K McGuire, Anne L Peters, Sangeeta Sawhney, Paul Strumph. Diabetes Care 2018
Times Cited: 98







List of co-cited articles
663 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of Diabetic Kidney Disease: Current and Future.
Tomotaka Yamazaki, Imari Mimura, Tetsuhiro Tanaka, Masaomi Nangaku. Diabetes Metab J 2021
42
2



Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Hiddo J L Heerspink, Niels Jongs, Glenn M Chertow, Anna Maria Langkilde, John J V McMurray, Ricardo Correa-Rotter, Peter Rossing, C David Sjöström, Bergur V Stefansson, Robert D Toto,[...]. Lancet Diabetes Endocrinol 2021
29
3

Dipyridamole prevents diabetes-induced alterations of kidney function in rats.
V Vallon, H Osswald. Naunyn Schmiedebergs Arch Pharmacol 1994
35
2

The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
Florian Gembardt, Christoph Bartaun, Natalia Jarzebska, Eric Mayoux, Vladimir T Todorov, Bernd Hohenstein, Christian Hugo. Am J Physiol Renal Physiol 2014
140
1


Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.
V Vallon, K Richter, R C Blantz, S Thomson, H Osswald. J Am Soc Nephrol 1999
251
1


High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
Hiroyuki Umino, Kazuhiro Hasegawa, Hitoshi Minakuchi, Hirokazu Muraoka, Takahisa Kawaguchi, Takeshi Kanda, Hirobumi Tokuyama, Shu Wakino, Hiroshi Itoh. Sci Rep 2018
85
1

Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Natalia Nowak, Jan Skupien, Adam M Smiles, Masayuki Yamanouchi, Monika A Niewczas, Andrzej T Galecki, Kevin L Duffin, Matthew D Breyer, Nick Pullen, Joseph V Bonventre,[...]. Kidney Int 2018
62
1

Renal Tubular Handling of Glucose and Fructose in Health and Disease.
Volker Vallon, Takahiko Nakagawa. Compr Physiol 2021
4
25




Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.
Hyun Mi Kang, Seon Ho Ahn, Peter Choi, Yi-An Ko, Seung Hyeok Han, Frank Chinga, Ae Seo Deok Park, Jianling Tao, Kumar Sharma, James Pullman,[...]. Nat Med 2015
710
1


Nitric oxide synthase in macula densa regulates glomerular capillary pressure.
C S Wilcox, W J Welch, F Murad, S S Gross, G Taylor, R Levi, H H Schmidt. Proc Natl Acad Sci U S A 1992
488
1

The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
Anne C Hesp, Jennifer A Schaub, Pottumarthi V Prasad, Volker Vallon, Gozewijn D Laverman, Petter Bjornstad, Daniël H van Raalte. Kidney Int 2020
64
1

Adenosine and kidney function.
Volker Vallon, Bernd Mühlbauer, Hartmut Osswald. Physiol Rev 2006
302
1

Olfactory receptor 544 reduces adiposity by steering fuel preference toward fats.
Chunyan Wu, Su Hyeon Hwang, Yaoyao Jia, Joobong Choi, Yeon-Ji Kim, Dahee Choi, Duleepa Pathiraja, In-Geol Choi, Seung-Hoi Koo, Sung-Joon Lee. J Clin Invest 2017
54
1

Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner.
Rui Chen, Elhadji M Dioum, Richard T Hogg, Robert D Gerard, Joseph A Garcia. J Biol Chem 2011
108
1

Autophagy Function and Regulation in Kidney Disease.
Gur P Kaushal, Kiran Chandrashekar, Luis A Juncos, Sudhir V Shah. Biomolecules 2020
36
2

Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.
Radica Z Alicic, Emily J Cox, Joshua J Neumiller, Katherine R Tuttle. Nat Rev Nephrol 2021
43
2

Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Nitin A Das, Andrea J Carpenter, Anthony Belenchia, Annayya R Aroor, Makoto Noda, Ulrich Siebenlist, Bysani Chandrasekar, Vincent G DeMarco. Cell Signal 2020
43
2

Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
Vajir Malek, Sachin V Suryavanshi, Nisha Sharma, Yogesh A Kulkarni, Shrikant R Mulay, Anil Bhanudas Gaikwad. Rev Physiol Biochem Pharmacol 2021
5
20

Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.
Maria P Rastaldi, Franco Ferrario, Laura Giardino, Giacomo Dell'Antonio, Carlo Grillo, Paolo Grillo, Frank Strutz, Gerhard A Müller, Giuliano Colasanti, Giuseppe D'Amico. Kidney Int 2002
328
1

Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
Steven G Coca, Girish N Nadkarni, Yuan Huang, Dennis G Moledina, Veena Rao, Jane Zhang, Bart Ferket, Susan T Crowley, Linda F Fried, Chirag R Parikh. J Am Soc Nephrol 2017
109
1

Autophagy in kidney homeostasis and disease.
Chengyuan Tang, Man J Livingston, Zhiwen Liu, Zheng Dong. Nat Rev Nephrol 2020
129
1


Azelaic Acid Induces Mitochondrial Biogenesis in Skeletal Muscle by Activation of Olfactory Receptor 544.
Trung Thanh Thach, Chunyan Wu, Kwang Yeon Hwang, Sung-Joon Lee. Front Physiol 2020
12
8

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, John M Lachin, Silvio E Inzucchi. N Engl J Med 2016
150
1

Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.
Ryoichi Bessho, Yumi Takiyama, Takao Takiyama, Hiroya Kitsunai, Yasutaka Takeda, Hidemitsu Sakagami, Tsuguhito Ota. Sci Rep 2019
72
1

mTOR as a central hub of nutrient signalling and cell growth.
Joungmok Kim, Kun-Liang Guan. Nat Cell Biol 2019
466
1


Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.
Gergely Gyimesi, Jonai Pujol-Giménez, Yoshikatsu Kanai, Matthias A Hediger. Pflugers Arch 2020
26
3

Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO.
J P Tolins, P J Shultz, L Raij, D M Brown, S M Mauer. Am J Physiol 1993
127
1

Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy.
Daniela Verzola, Maria Teresa Gandolfo, Gianfranco Gaetani, Annamaria Ferraris, Rosa Mangerini, Franco Ferrario, Barbara Villaggio, Fabio Gianiorio, Fanny Tosetti, Ursula Weiss,[...]. Am J Physiol Renal Physiol 2008
171
1

Regulation of renal sodium transporters during severe inflammation.
Christoph Schmidt, Klaus Höcherl, Frank Schweda, Armin Kurtz, Michael Bucher. J Am Soc Nephrol 2007
123
1

Dapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 Cells.
Jing Xu, Munehiro Kitada, Yoshio Ogura, Haijie Liu, Daisuke Koya. Cells 2021
25
4

Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy.
Yu Ho Lee, Sang Hoon Kim, Jun Mo Kang, Jin Hyung Heo, Dong-Jin Kim, Seon Hwa Park, MinJi Sung, Jaehee Kim, Jisu Oh, Dong Ho Yang,[...]. Am J Physiol Renal Physiol 2019
80
1

Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
C David Mazer, Gregory M T Hare, Philip W Connelly, Richard E Gilbert, Nadine Shehata, Adrian Quan, Hwee Teoh, Lawrence A Leiter, Bernard Zinman, Peter Jüni,[...]. Circulation 2020
144
1

Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice.
Shuiling Zhao, Chao-Sheng Lo, Kana N Miyata, Anindya Ghosh, Xin-Ping Zhao, Isabelle Chenier, Jean-Francois Cailhier, Jean Ethier, Jean-Baptiste Lattouf, Janos G Filep,[...]. Diabetes 2021
7
14

Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat.
Takahiro Masuda, Yuko Watanabe, Keiko Fukuda, Minami Watanabe, Akira Onishi, Ken Ohara, Toshimi Imai, Hermann Koepsell, Shigeaki Muto, Volker Vallon,[...]. Am J Physiol Renal Physiol 2018
29
3

SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
Aleksandra Novikov, Yiling Fu, Winnie Huang, Brent Freeman, Rohit Patel, Charlotte van Ginkel, Hermann Koepsell, Meinrad Busslinger, Akira Onishi, Josselin Nespoux,[...]. Am J Physiol Renal Physiol 2019
56
1

The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice.
Zi Li, Maki Murakoshi, Saki Ichikawa, Takeo Koshida, Eri Adachi, Chigure Suzuki, Seiji Ueda, Tomohito Gohda, Yusuke Suzuki. FEBS Open Bio 2020
5
20

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Linda A Gallo, Micheal S Ward, Amelia K Fotheringham, Aowen Zhuang, Danielle J Borg, Nicole B Flemming, Ben M Harvie, Toni L Kinneally, Shang-Ming Yeh, Domenica A McCarthy,[...]. Sci Rep 2016
99
1

Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.
Kento Kitada, Daisuke Nakano, Hiroyuki Ohsaki, Hirofumi Hitomi, Tohru Minamino, Junichi Yatabe, Robin A Felder, Hirohito Mori, Tsutomu Masaki, Hiroyuki Kobori,[...]. J Diabetes Complications 2014
81
1

Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-κB-mediated transcription of SGLT2 in renal tubular epithelial cells.
Menglu Fu, Jing Yu, Zhihui Chen, Ying Tang, Ruolan Dong, Yan Yang, Jinlan Luo, Shuiqing Hu, Ling Tu, Xizhen Xu. Mol Cell Endocrinol 2021
7
14

The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial.
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. Expert Opin Pharmacother 2017
7
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.